Paul Elliot Mann Sells 316,666 Shares of ASP Isotopes Inc. (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) CEO Paul Elliot Mann sold 316,666 shares of the firm’s stock in a transaction dated Thursday, April 17th. The stock was sold at an average price of $5.62, for a total value of $1,779,662.92. Following the transaction, the chief executive officer now directly owns 7,315,454 shares in the company, valued at approximately $41,112,851.48. The trade was a 4.15 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Paul Elliot Mann also recently made the following trade(s):

  • On Tuesday, April 15th, Paul Elliot Mann sold 316,667 shares of ASP Isotopes stock. The shares were sold at an average price of $5.75, for a total value of $1,820,835.25.

ASP Isotopes Trading Up 2.6 %

ASPI opened at $5.84 on Friday. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a 52 week low of $1.86 and a 52 week high of $9.33. The business’s 50 day moving average is $4.74 and its two-hundred day moving average is $5.18. The firm has a market cap of $420.88 million, a price-to-earnings ratio of -9.57 and a beta of 3.44.

Hedge Funds Weigh In On ASP Isotopes

A number of hedge funds have recently modified their holdings of the business. Charles Schwab Investment Management Inc. boosted its stake in ASP Isotopes by 16.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock worth $334,000 after purchasing an additional 17,159 shares during the period. The Manufacturers Life Insurance Company purchased a new stake in shares of ASP Isotopes in the third quarter valued at about $52,000. State Street Corp boosted its stake in shares of ASP Isotopes by 12.8% during the third quarter. State Street Corp now owns 853,695 shares of the company’s stock worth $2,373,000 after buying an additional 96,604 shares during the period. Jane Street Group LLC grew its holdings in shares of ASP Isotopes by 31.7% during the third quarter. Jane Street Group LLC now owns 145,969 shares of the company’s stock worth $406,000 after buying an additional 35,166 shares during the last quarter. Finally, Barclays PLC increased its position in ASP Isotopes by 438.5% in the 3rd quarter. Barclays PLC now owns 72,330 shares of the company’s stock valued at $201,000 after acquiring an additional 58,897 shares during the period. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Articles

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.